Karin Samuelsson
About
In The Last Decade
Karin Samuelsson
20 papers receiving 468 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 314
- Physiology 104
- Organic Chemistry 100
- Spectroscopy 85
- Biochemistry 72
Countries citing papers authored by Karin Samuelsson
This map shows the geographic impact of Karin Samuelsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Samuelsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Samuelsson more than expected).
Fields of papers citing papers by Karin Samuelsson
This network shows the impact of papers produced by Karin Samuelsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Samuelsson. The network helps show where Karin Samuelsson may publish in the future.
Co-authorship network of co-authors of Karin Samuelsson
This figure shows the co-authorship network connecting the top 25 collaborators of Karin Samuelsson. A scholar is included among the top collaborators of Karin Samuelsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Samuelsson. Karin Samuelsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 0 | |
| 3 | 18 | |
| 4 | Packaging logistics at Schenker - a study of possibilities and advantages | 1 |
| 5 | 2 | |
| 6 | 12 | |
| 7 | [Neurosarcoidosis can occur without any other signs of sarcoidosis]. | 1 |
| 8 | 16 | |
| 9 | 1 | |
| 10 | Splenic transplantation in Gaucher disease. | 4 |
| 11 | 40 | |
| 12 | 9 | |
| 13 | 34 | |
| 14 | 20 | |
| 15 | 45 | |
| 16 | 47 | |
| 17 | 47 | |
| 18 | 52 | |
| 19 | 14 | |
| 20 | 34 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.